Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001345281-25-000002
Filing Date
2025-05-22
Accepted
2025-05-22 17:41:44
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5809
  Complete submission text file 0001345281-25-000002.txt   7435
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14 LEXINGTON WAY LONG VALLEY NJ 07853
Business Address
Masi Dina (Reporting) CIK: 0001345281 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 25978434